Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Azhagendran Sivalingam"'
Autor:
Kamaraj Pattabhi, Jerard Selvam, Azhagendran Sivalingam, Piyalee Pal, Savitha Kasivishwanathan, Suresh Arunachalam, T S Selvavinayagam, Prabhdeep Kaur
Publikováno v:
Journal of Public Health and Primary Care, Vol 3, Iss 3, Pp 68-75 (2022)
Background: Despite advances in hypertension care, developing countries have a high burden of uncontrolled blood pressure (BP). The Government of Tamil Nadu, India, initiated a noncommunicable disease program to improve hypertension management in pub
Externí odkaz:
https://doaj.org/article/25447c211376484c9b9b5e5c1f8d116b
Autor:
Sharan Murali, Manikandanesan Sakthivel, Kamaraj Pattabi, Vettrichelvan Venkatasamy, Jeromie Wesley Vivian Thangaraj, Anita Shete, Alby John Varghese, Jaganathan Arjun, Chethrapilly Purushothaman Girish Kumar, Pragya D Yadav, Rima Sahay, Triparna Majumdar, Manisha Dudhmal, Azhagendran Sivalingam, Sudha Rani Dhanapal, Augustine Durai Samy, Vijayaprabha Radhakrishnan, Murali Mohan Muni Krishnaiah, Suresh Arunachalam, Punita Muni Krishna Gandhi, Elavarasu Govindasamy, Prabhakaran Chinnappan, Dhana Priya Vadhani Sekar, Prakash Marappan, Ezhil Pounraj, Parasuraman Ganeshkumar, Murugesan Jagadeesan, Manish Narnaware, Gagandeep Singh Bedi, Prabhdeep Kaur, Manoj Murhekar
Publikováno v:
Vaccines, Vol 10, Iss 6, p 970 (2022)
We estimated the effectiveness of two doses of the ChAdOx1 nCoV-19 (Covishield) vaccine against any COVID-19 infection among individuals ≥45 years in Chennai, Tamil Nadu, India. A community-based cohort study was conducted from May to September 202
Externí odkaz:
https://doaj.org/article/e2ef5ca5ea0240de99eb4bca0701b632
Autor:
Sharan Murali, Manikandanesan Sakthivel, Kamaraj P, Vettrichelvan Venkataswamy, Jeromie Wesley Vivian Thangaraj, Anita Shete, Alby John, Jaganathan Arjun, Girish Kumar C P, Pragya D Yadav, Rima Sahay, Triparna Majumdar, Manisha Dhudhmal, Azhagendran Sivalingam, Sudha Rani D, Augustine D, Vijayaprabha R, Murali Mohan M, Suresh A, Punita M, Elavarasu G, Prabhakaran C, Dhana Priya Vadhani S, Prakash M, Ezhil P, Ganeshkumar Parasuraman, Jagadeesan M, Manish S Narnaware, Gagandeep Singh Bedi, Prabhdeep Kaur, Manoj V Murhekar
BackgroundIndia experienced the second wave of the COVID-19 pandemic in March 2021, driven by the delta variant. Apprehensions around the usefulness of vaccines against delta variant posed a risk to the vaccination program. Therefore, we estimated th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c308055437ad072949a0837fcc8a7574
https://doi.org/10.1101/2022.04.15.22273859
https://doi.org/10.1101/2022.04.15.22273859
Autor:
Prabhdeep Kaur, Kamaraj Pattabhi, Jerard Selvam, Azhagendran Sivalingam, Piyalee Pal, Savitha Kasivishwanathan, Suresh Arunachalam, TS Selvavinayagam
Publikováno v:
Journal of Public Health and Primary Care. 3:68